Amgros 2026 1.479.a

Summary

The tender concerns framework agreements for medicines through Amgros I/S. The bidder is expected to supply the medicines listed in the relevant lot, with the understanding that the framework agreements are non-exclusive, there is no purchase obligation, and the hospital pharmacies are not obliged to use the agreements. Price is the only award criterion. The exact exclusion grounds, qualification requirements and contract performance conditions must be checked in the tender documents, but it is known that the medicines must have a marketing authorisation valid for Denmark and that the supplier must hold an EU/EEA authorisation for manufacturing, importing or wholesale distribution of medicines.